Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Biomarkers of immune activation to screen for severe, acute GVHD.

August KJ, Chiang KY, Bostick RM, Flanders WD, Waller EK, Langston A, Worthington-White D, Rowland P, Moore KF, Khoury HJ, Horan JT.

Bone Marrow Transplant. 2011 Apr;46(4):601-4. doi: 10.1038/bmt.2010.165. Epub 2010 Jul 12. No abstract available.

PMID:
20622904
2.

Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease.

Biedermann BC, Tsakiris DA, Gregor M, Pober JS, Gratwohl A.

Bone Marrow Transplant. 2003 Dec;32(11):1077-84.

PMID:
14625579
3.

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.

Fowler DH, Foley J, Whit-Shan Hou J, Odom J, Castro K, Steinberg SM, Gea-Banacloche J, Kasten-Sportes C, Gress RE, Bishop MR.

Clin Gastroenterol Hepatol. 2004 Mar;2(3):237-45.

PMID:
15017608
4.

Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.

Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW.

Exp Hematol. 2006 Jun;34(6):796-801.

PMID:
16728285
5.

Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Lee KH, Choi SJ, Lee JH, Lee JS, Kim WK, Lee KB, Sohn SK, Kim JG, Kim DH, Seol M, Lee YS, Lee JH.

Haematologica. 2005 Jul;90(7):939-48.

6.

Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.

Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G.

Transplantation. 2009 Dec 15;88(11):1261-72. doi: 10.1097/TP.0b013e3181bc267e.

PMID:
19996925
7.

Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Avanzini MA, Maccario R, Locatelli F, Giebel S, Santos CD, Bernardo ME, Pagliara D, Montagna D, Longo S, Amendola G, Marconi M.

Exp Hematol. 2006 Oct;34(10):1429-34.

PMID:
16982336
8.

Procalcitonin and C-reactive protein serum levels after hematopoietic stem-cell transplant.

Azarpira N, Ramzi M, Aghdaie M, Daraie M.

Exp Clin Transplant. 2009 Jun;7(2):115-8.

9.

[A method for modeling skin explants--an in vitro predictive test for graft vs host disease in allogenic hematopoietic cell transplantation].

Hromadníková I, Sedlácek P, Starý J, Vavrinec J, Cermáková-Frantlová M, Stechová K, Houbová B, Vítek A, Sajdová J, Sviland L, Dickinson AM.

Cas Lek Cesk. 2001 Feb 15;140(3):73-8. Czech.

PMID:
11284422
10.

Plasma biomarkers in graft-versus-host disease: a new era?

Paczesny S, Levine JE, Braun TM, Ferrara JL.

Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):33-8. doi: 10.1016/j.bbmt.2008.10.027. Review.

11.

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zürbig P, Kellmann M, Ganser A.

Blood. 2007 Jun 15;109(12):5511-9. Epub 2007 Mar 5.

12.

Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation.

Chiusolo P, Metafuni E, Giammarco S, Bellesi S, Piccirillo N, Fanali C, Castagnola M, Zuppi C, De Michele T, Leone G, Sica S.

Blood. 2012 Nov 22;120(22):4443-4. doi: 10.1182/blood-2012-08-447326. No abstract available.

14.

A biomarker panel for acute graft-versus-host disease.

Paczesny S, Krijanovski OI, Braun TM, Choi SW, Clouthier SG, Kuick R, Misek DE, Cooke KR, Kitko CL, Weyand A, Bickley D, Jones D, Whitfield J, Reddy P, Levine JE, Hanash SM, Ferrara JL.

Blood. 2009 Jan 8;113(2):273-8. doi: 10.1182/blood-2008-07-167098. Epub 2008 Oct 2.

15.

[GVHD and GVL].

Teshima T.

Rinsho Ketsueki. 2009 Oct;50(10):1407-19. Review. Japanese. No abstract available.

PMID:
19915349
16.

Histological and immunohistochemical characterisation of conjunctival graft vs host disease following haematopoietic stem cell transplantation.

Auw-Haedrich C, Potsch C, Böhringer D, Mittelviefhaus H, Maier P, Reinhard T, Freudenberg N, Finke J, Coupland SE.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):1001-7. Epub 2006 Nov 22.

PMID:
17120011
17.

[Cutaneous manifestations of graft-versus-host disease].

Karrer S, Holler E, Szeimies RM.

Med Klin (Munich). 2001 Aug 15;96(8):457-66. Review. German.

PMID:
11560046
18.
19.

Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).

Bacigalupo A, Oneto R, Bruno B, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Lombardi A, Frassoni F, Van Lint MT.

Bone Marrow Transplant. 2001 Dec;28(11):1041-5.

20.

Serum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic cell transplantation.

Toubai T, Shono Y, Tone S, Ibata M, Kato N, Malter C, Lowler KP, Ota S, Tanaka J, Asaka M, Imamura M.

Leuk Lymphoma. 2009 May;50(5):844-7. doi: 10.1080/10428190902836099. No abstract available.

PMID:
19452322
Items per page

Supplemental Content

Write to the Help Desk